Journal of Controlled Release · 2025 · 15 citations · 34 references
PharmacyOncologyPharmacologyCancer ImmunologyDrug DeliveryTumor ImmunologyAntibody ConjugatesAntibody ConjugationAntibody-antigen RecognitionAntibody-drug ConjugatesCancer ImmunotherapyImmunogenicity Of Therapeutic AntibodiesAntibody-drug Conjugate AntibodiesAntibody-drug Conjugate LinkersAntibody-drug Conjugate TherapyAntibody-drug LinkersIntra-tumor HeterogeneityPeptide Linker DesignPeptide-drug ConjugatesTumor-targeting Peptides
34
Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer
Sunil Verma, David Miles, Luca Gianni et al. · New England Journal of Medicine · 2012 · 3.8K citations · Full text
Medicine, Oncology, Pharmacology +14
Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer
Shanu Modi, William Jacot, Toshinari Yamashita et al. · New England Journal of Medicine · 2022 · 2.5K citations · Full text
Medicine, Oncology, Pharmacology +17
Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer
Aditya Bardia, Sara A. Hurvitz, Sara M. Tolaney et al. · New England Journal of Medicine · 2021 · 1.5K citations · Full text
Medicine, Oncology, Pharmacology +17